Yechezkel Barenholz
CSO and Founder
Claimed by owner LipoCure
Former names:
Liposome-based Nano Drugs
LipoCure
About
LipoCure is developing a number of therapeutics utilizing proprietary liposome-based nano drugs with novel drug-loading capabilities and drug-release mechanisms. LipoCure's proprietary platform implements an approach that allows for remote drug loading into nano-liposomes and concomitant controlled release of the drugs at the targeted site.
This technology is designed to produce an enhanced permeability and retention effect, a significantly improved therapeutic effect, and reduced side effects. It can be used in conjunction with several well-established drugs used for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer.
LipoCure's founder is professor Yechezkel Barenholz, the co-developer of Doxil.
This technology is designed to produce an enhanced permeability and retention effect, a significantly improved therapeutic effect, and reduced side effects. It can be used in conjunction with several well-established drugs used for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer.
LipoCure's founder is professor Yechezkel Barenholz, the co-developer of Doxil.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
LC-400, LC-100, LC-200, LC-300
Geographic markets
United States
The Team
(3)
YB
YHA
Yanir H. Aldouby
COO
MBG
Moria Barlev- Gross
R&D
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
A Round
$8M
Sep 2017
2 Investors
$8M
Others
Academic Techonology
Nov 2005
undefined
Injectable nano liposomal chemotherapy treatment
Media gallery
(1)Locations
Israel
Hadassah Ein Kerem Campus, Jerusalem, Israel
Locations
Israel
Hadassah Ein Kerem Campus, Jerusalem, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,